SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001157523-14-002083
Filing Date
2014-05-12
Accepted
2014-05-12 09:15:36
Documents
12
Period of Report
2014-05-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AKORN, INC. 8-K a50862962.htm 8-K 44445
2 EXHIBIT 2.1 a50862962ex2_1.htm EX-2.1 912604
3 EXHIBIT 99.1 a50862962ex99_1.htm EX-99.1 15461
4 GRAPHIC slide1.jpg GRAPHIC 391811
5 GRAPHIC slide2.jpg GRAPHIC 424078
6 GRAPHIC slide3.jpg GRAPHIC 330932
7 GRAPHIC slide4.jpg GRAPHIC 262997
8 GRAPHIC slide5.jpg GRAPHIC 242545
9 GRAPHIC slide6.jpg GRAPHIC 269202
10 GRAPHIC slide7.jpg GRAPHIC 250141
11 GRAPHIC slide8.jpg GRAPHIC 274791
12 GRAPHIC slide9.jpg GRAPHIC 355249
  Complete submission text file 0001157523-14-002083.txt   4835048
Mailing Address 1925 W. FIELD COURT, SUITE 300 LAKE FOREST IL 60045
Business Address 1925 W. FIELD COURT, SUITE 300 LAKE FOREST IL 60045 847-279-6100
AKORN INC (Filer) CIK: 0000003116 (see all company filings)

IRS No.: 720717400 | State of Incorp.: LA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32360 | Film No.: 14831531
SIC: 2834 Pharmaceutical Preparations